User experience

General Mills Canada elevates its support for sport in Canada with new Canadian Paralympic Committee sponsorship

Retrieved on: 
Wednesday, April 3, 2024

TORONTO, April 03, 2024 (GLOBE NEWSWIRE) --  With this summer’s Olympic and Paralympic Games in Paris quickly approaching, General Mills Canada is proud to expand its support for Canadian athletes by becoming an “Official Supporter” of the Canadian Paralympic Committee (CPC).

Key Points: 
  • TORONTO, April 03, 2024 (GLOBE NEWSWIRE) --  With this summer’s Olympic and Paralympic Games in Paris quickly approaching, General Mills Canada is proud to expand its support for Canadian athletes by becoming an “Official Supporter” of the Canadian Paralympic Committee (CPC).
  • “We are so pleased to partner with General Mills, who has shown a longstanding commitment to showcasing the power of sport,” said Karen O’Neill, CEO, Canadian Paralympic Committee.
  • “Paralympians are incredible athletes with so many diverse journeys along their way to reaching the pinnacle of sport, and this partnership will bring Paralympic stories into more homes across Canada.
  • To kickstart its partnership, General Mills participated last week in the ParaTough Cup in Toronto, the flagship fundraising event of the Paralympic Foundation of Canada, the philanthropic arm of CPC.

UHN Joins the Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury

Retrieved on: 
Wednesday, April 3, 2024

LSALT peptide is the Company’s lead drug candidate for preventing and treating inflammation injury in the kidneys, lungs and liver.

Key Points: 
  • LSALT peptide is the Company’s lead drug candidate for preventing and treating inflammation injury in the kidneys, lungs and liver.
  • The CS-AKI Phase II trial is an international multi-center, randomized, double-blind, placebo-controlled study of LSALT peptide.
  • Details of the Phase II trial, entitled “ Phase 2 Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of LSALT peptide for the Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery” can be viewed at clinicaltrials.gov .
  • There is no treatment available in the market today that prevents acute kidney injury of the type commonly experienced by on-pump cardiac surgery patients.

Infobip Gears Up for Second Edition of Developer Shift Conference in the U.S.

Retrieved on: 
Monday, April 8, 2024

Infobip Shift Miami , the American counterpart of Croatia's renowned developer conference, is returning to the iconic Perez Art Museum for its second annual edition from April 22nd to 24th, 2024.

Key Points: 
  • Infobip Shift Miami , the American counterpart of Croatia's renowned developer conference, is returning to the iconic Perez Art Museum for its second annual edition from April 22nd to 24th, 2024.
  • Our goal is to establish Infobip Shift Miami as an annual cherished event within the American developer community," explains Nikola Radišić, head of the Infobip Shift team.
  • Infobip Shift Miami 2024 demonstrates our strategic approach to connecting the developer community around this unique event," concludes Nikola Pavešić, Director of Developer Experience and Startups at Infobip.
  • Following Infobip Shift in Miami, the European edition of the conference is scheduled to take place at ŠC Višnjik in Zadar on September 16 and 17, 2024.

University of Calgary Joins the Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury

Retrieved on: 
Friday, March 15, 2024

LSALT peptide is the Company’s lead drug candidate for preventing and treating inflammation injury in the kidneys, lungs and liver.

Key Points: 
  • LSALT peptide is the Company’s lead drug candidate for preventing and treating inflammation injury in the kidneys, lungs and liver.
  • “We know that acute kidney injury impairs recovery and can negatively affect long-term outcomes following heart surgery.
  • The CS-AKI Phase II trial is an international multi-center, randomized, double-blind, placebo-controlled study of LSALT peptide.
  • Details of the Phase II trial, entitled “ Phase 2 Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of LSALT peptide for the Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery” can be viewed at clinicaltrials.gov .

MetLife Receives Prestigious CIO 100 Award

Retrieved on: 
Wednesday, March 20, 2024

MetLife, Inc. (NYSE: MET) Holdings Digital Customer Experience has earned the company a spot as one of the prestigious 2024 CIO 100 award winners.

Key Points: 
  • MetLife, Inc. (NYSE: MET) Holdings Digital Customer Experience has earned the company a spot as one of the prestigious 2024 CIO 100 award winners.
  • For more than 30 years, the CIO 100 Awards from Foundry’s CIO have recognized innovative organizations around the world that exemplify the highest level of strategic and operational excellence in information technology.
  • The Digital Customer Experience is a contemporary digital self-service solution for the MetLife Holdings business segment, which includes Long Term Care, Retail Life, Retail Annuity, and Group Annuity products.
  • “Our cross-functional technology and business teams partnered to make the MetLife Holdings Digital Customer Experience a reality," said Ramy Tadros, MetLife’s Head of U.S. Business and MetLife Holdings.

Central Bark® Signs Largest Multi-Unit Franchise Deal to Date for Five New Locations Across North Philadelphia and Suburbs

Retrieved on: 
Wednesday, March 27, 2024

DOYLESTOWN, Pa., March 27, 2024 /PRNewswire/ -- Central Bark®, the premier whole dog care franchise and industry pioneer, is proud to announce the signing of its largest multi-unit franchise agreement to date in Doylestown, PA, and the surrounding North Philadelphia suburbs.

Key Points: 
  • Leading Central Bark's growth in North Philadelphia is Christian Lampone, who just executed the multi-unit development agreement.
  • "This opportunity with Central Bark is a combination of my passion and investment strategy and my plans for the future.
  • "Christian is an amazing addition to our rapidly growing Central Bark franchise family," said Tim Weiderhoft, Ed.D., CFE, chief development officer for Central Bark.
  • And we could not be happier that Christian has decided to join Central Bark and bring our unique approach to Doylestown and the North Philadelphia suburbs.

Adswerve Named 2024 Adobe Digital Experience Emerging Partner of the Year - Americas

Retrieved on: 
Monday, March 25, 2024

DENVER, March 25, 2024 /PRNewswire-PRWeb/ -- Adswerve, an award-winning data, media and technology consultancy and Adobe Gold partner, today announced that it has been honored as the 2024 Adobe Digital Experience Emerging Partner of the Year – Americas during Partner Day at Adobe Summit. This prestigious recognition underscores Adswerve's leadership in driving customer success through innovative digital marketing strategies and analytics solutions. As the first partner to achieve the Adobe Customer Journey Analytics specialization, Adswerve's dedicated team of analytics and media experts is committed to maximizing every customer interaction.

Key Points: 
  • DENVER, March 25, 2024 /PRNewswire-PRWeb/ -- Adswerve , an award-winning data, media and technology consultancy and Adobe Gold partner, today announced that it has been honored as the 2024 Adobe Digital Experience Emerging Partner of the Year – Americas during Partner Day at Adobe Summit.
  • "Being named the 2024 Adobe Digital Experience Emerging Partner of the Year – Americas reaffirms our unwavering commitment to equipping marketers with cutting-edge data and analytics solutions that drive measurable results," said Roger Berdusco, CEO of Adswerve.
  • The Adobe Partner Awards celebrate outstanding partners who demonstrate exceptional performance, dedication, and collaboration in delivering impactful solutions to customers.
  • By leveraging Adobe Analytics, Adobe Target, Adobe Real-Time CDP, Adobe Journey Optimizer, and Adobe Customer Journey Analytics, Adswerve helps clients optimize their campaigns, improve customer experiences, and deliver outstanding results.

Bybit Card Honored with Prestigious iF DESIGN AWARD 2024 for Pioneering Crypto Adoption

Retrieved on: 
Monday, March 18, 2024

DUBAI, UAE, March 18, 2024 /PRNewswire/ -- Bybit , one of the world's top three crypto exchanges by volume, is honored to share that Bybit Card has been recognized with the esteemed iF DESIGN AWARD 2024 in the User Experience category .

Key Points: 
  • DUBAI, UAE, March 18, 2024 /PRNewswire/ -- Bybit , one of the world's top three crypto exchanges by volume, is honored to share that Bybit Card has been recognized with the esteemed iF DESIGN AWARD 2024 in the User Experience category .
  • The iF DESIGN AWARD is globally renowned as one of the most prestigious honors in design.
  • We are humbled to have Bybit Card's pioneering design and innovation distinguished through the iF DESIGN AWARD.
  • "We extend our deepest gratitude to iF International Forum Design for recognizing Bybit Card with this prestigious honor," said Ben Zhou, co-founder and CEO at Bybit.

Bybit Card Honored with Prestigious iF DESIGN AWARD 2024 for Pioneering Crypto Adoption

Retrieved on: 
Monday, March 18, 2024

DUBAI, UAE, March 18, 2024 /PRNewswire/ -- Bybit , one of the world's top three crypto exchanges by volume, is honored to share that Bybit Card has been recognized with the esteemed iF DESIGN AWARD 2024 in the User Experience category .

Key Points: 
  • DUBAI, UAE, March 18, 2024 /PRNewswire/ -- Bybit , one of the world's top three crypto exchanges by volume, is honored to share that Bybit Card has been recognized with the esteemed iF DESIGN AWARD 2024 in the User Experience category .
  • The iF DESIGN AWARD is globally renowned as one of the most prestigious honors in design.
  • We are humbled to have Bybit Card's pioneering design and innovation distinguished through the iF DESIGN AWARD.
  • "We extend our deepest gratitude to iF International Forum Design for recognizing Bybit Card with this prestigious honor," said Ben Zhou, co-founder and CEO at Bybit.

Global and China Automotive Functional Safety and Safety Of The Intended Functionality (SOTIF) Research Report 2024

Retrieved on: 
Friday, March 15, 2024

DUBLIN, March 14, 2024 /PRNewswire/ -- The "Global and China Automotive Functional Safety and Safety Of The Intended Functionality (SOTIF) Research Report, 2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 14, 2024 /PRNewswire/ -- The "Global and China Automotive Functional Safety and Safety Of The Intended Functionality (SOTIF) Research Report, 2024" report has been added to ResearchAndMarkets.com's offering.
  • As a result, functional safety and SOTIF (safety of the intended functionality) have caught more attention, especially in the field of autonomous vehicles.
  • In 2023, standards and policies have speeded up the development of automotive functional safety and SOTIF in China.
  • Besides setting up functional safety teams, they actively participate in functional safety training, cooperate with third-party institutions, strictly control self-developed products and vehicle functional safety products and processes, and take suppliers' functional safety development capabilities and product functional safety capabilities as the criteria to enter their supply chains.